GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Ethema Health GRST · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$18.8m

FY2016FY2025

Net income

−$2.2m

FY2016FY2025

Free cash flow

−$310,616

FY2016FY2025

Shareholders' equity

−$9.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$18.8m$6.0m$5.3m$4.8m$1.9m$338,996$359,947$432,515$929,416—
Operating income−$260,135−$1.3m−$542,000$489,117$2,105−$163,000−$4.0m−$2.9m−$1.5m−$791,000
Net income−$2.2m−$2.1m$1.2m$247,880−$1.5m$3.1m−$15.0m−$8.2m−$1.4m−$261,000
Diluted earnings per share-0.00-0.000.000.00-0.000.00-0.10-0.12-0.00-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$28.8m$12.2m$11.5m$6.6m$6.6m$3.8m$3.2m$12.7m$12.3m$460,055
Cash and short-term investments$59,509$244,771$68,573$140,757$48,822$780,949—$24,674$339$4,779
Total liabilities$38.4m$19.6m$17.7m$15.4m$16.0m$18.4m$23.2m$20.4m$14.0m$3.6m
Debt$23.7m$17.2m$14.6m$11.4m$11.5m$9.2m$4.7m$11.3m$7.5m$306,374
Shareholders' equity−$9.6m−$7.5m−$6.2m−$9.7m−$10.3m−$15.3m−$20.0m−$7.7m−$1.8m−$3.2m
Shares outstanding7,726m7,729m3,729m4,276m3,579m2,207m155m66m764m49m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$32,876−$455,704−$530,157$1.6m−$85,567−$2.9m−$2.9m−$1.5m−$4.4m−$4,142
Capital spending−$277,740−$300,259−$40,602−$315,822−$132,832−$95,254−$95,254−$1.4m−$2.0m−$436,372
Free cash flow−$310,616−$755,963−$570,759$1.3m−$218,399−$3.0m−$3.0m−$2.9m−$6.4m−$440,514
Dividends paid————−$24,000−$37,818−$37,818−$37,818−$37,818—

Latest quarters

By quarter end

Jun 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue$4.8m$4.8m$5.5m$4.9m$1.5m$1.5m$1.8m$1.5m
Operating income−$368,216−$368,216$546,015$209,500−$103,000−$102,836−$724,000−$278,000
Net income−$1.1m−$1.1m$66,136−$295,500−$326,000−$325,745−$1.0m−$363,000
Diluted earnings per share-0.00-0.000.00—-0.00-0.00-0.00-0.00
Total assets$28.8m$28.8m$30.3m$28.9m$12.2m$12.2m$12.3m$12.3m
Cash and short-term investments$59,509—$114,030$441,700$244,771—$60,862$31,102
Debt$5.1m$3.8m$16.5m$12.3m$7.3m$6,149$7.2m$7.1m
Shareholders' equity−$9.6m−$9.6m−$8.6m−$8.6m−$7.5m−$7.5m−$7.1m−$8.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue57.3%123.2%19.6%
Operating income—9.8%-5.3%
Net income——6.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-6.4%-4.7%-4.9%—
Net margin-17.3%-8.2%-3.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.9-0.70.21.7-0.60.6—-0.0-0.3-0.0
Price to sales0.10.20.10.10.55.70.00.10.5—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return60%43%-13%-56%-71%598%-85%7%1292%-8%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.